The DOI matches its Crossref record.
Hextend[registered sign], a Physiologically Balanced Plasma Expander for Large Volume Use in Major Surgery: A Randomized Phase III Clinical Trial
Abstract
UNLABELLED: Hextend (BioTime, Inc., Berkeley, CA) is a new plasma volume expander containing 6% hetastarch, balanced electrolytes, a lactate buffer, and physiological levels of glucose. In preclinical studies, its use in shock models was associated with an improvement in outcome compared with alternatives, such as albumin or 6% hetastarch in saline. In a prospective, randomized, two-center study (n = 120), we compared the efficacy and safety of Hextend versus 6% hetastarch in saline (HES) for the treatment of hypovolemia during major surgery. Patients at one center had a blood sample drawn at the beginning and the end of surgery for thromboelastographic (TEG) analysis. Hextend was as effective as HES for the treatment of hypovolemia. Patients received an average of 1596 mL of Hextend: 42% received >20 mL/kg up to a total of 5000 mL. No patient received albumin. Hextend-treated patients required less intraoperative calcium (4 vs 220 mg; P < 0.05). In a subset analysis of patients receiving red blood cell transfusions (n = 56; 47%), Hextend-treated patients had a lower mean estimated blood loss (956 mL less; P = 0.02) and were less likely to receive calcium supplementation (P = 0.04). Patients receiving HES demonstrated significant prolongation of time to onset of clot formation (based on TEG) not seen in the Hextend patients (P < 0.05). No Hextend patient experienced a related serious adverse event, and there was no difference in the total number of adverse events between the two groups. The results of this study demonstrate that Hextend, with its novel buffered, balanced electrolyte formulation, is as effective as 6% hetastarch in saline for the treatment of hypovolemia and may be a safe alternative even when used in volumes up to 5 L. IMPLICATIONS: Hextend (BioTime, Inc., Berkeley, CA) is a new plasma volume expander containing 6% hetastarch, balanced electrolytes, a lactate buffer, and a physiological level of glucose. It is as effective as 6% hetastarch in saline for the treatment of hypovolemia but has a more favorable side effects profile in volumes of up to 5 L compared with 6% hetastarch in saline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update
Hollenberg, S. M., Ahrens, T. S., Annane, D., Astiz, M. E., Chalfin, D. B., Dasta, J. F., Heard, S. O., Martin, C., Napolitano, L. M., Susla, G. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000139761.05492.d6 · Cited by 521
Waters, J. H., Gottlieb, A., Schoenwald, P., Popovich, M. J., Sprung, J., & Nelson, D. R. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200110000-00004 · Cited by 410
O???Malley, C. M. N., Frumento, R. J., Hardy, M. A., Benvenisty, A. I., Brentjens, T. E., Mercer, J. S., & Bennett-Guerrero, E. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000150939.28904.81 · Cited by 410
Self-citationPerioperative Fluid Management and Clinical Outcomes in Adults
Grocott, M. P. W., Mythen, M. G., & Gan, T. J. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000148691.33690.ac · Cited by 404
Self-citationMcCluskey, S. A., Karkouti, K., Wijeysundera, D., Minkovich, L., Tait, G., & Beattie, W. S. (2013) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318293d81e · Cited by 353
Metadata
- Authors
- Gan, T. J., Bennett-Guerrero, E., Phillips-Bute, B., Wakeling, H., Moskowitz, D. M., Olufolabi, Y., Konstadt, S. N., Bradford, C., Glass, P. S. A., Machin, S. J., & Mythen, M. G.
- Venue
- Anesthesia & Analgesia
- Published
- 1999-05
- Volume
- 88
- Issue
- 5
- Pages
- 992-998
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W170227579
- Cited by
- 223
- References
- 0
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hextend[registered sign], a Physiologically Balanced Plasma Expander for Large Volume Use in Major Surgery: A Randomized Phase III Clinical Trial. https://app.cochat.ai/papers/10.1097/00000539-199905000-00005
- The paper
- Gan, T. J., Bennett-Guerrero, E., Phillips-Bute, B., Wakeling, H., Moskowitz, D. M., Olufolabi, Y., Konstadt, S. N., Bradford, C., Glass, P. S. A., Machin, S. J., & Mythen, M. G. (1999). Hextend[registered sign], a Physiologically Balanced Plasma Expander for Large Volume Use in Major Surgery: A Randomized Phase III Clinical Trial. Anesthesia & Analgesia. https://doi.org/10.1097/00000539-199905000-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.